Your browser doesn't support javascript.
loading
Stabilizing Peri-Stent Restenosis Using a Novel Therapeutic Carrier.
Kee, Patrick H; Moody, Melanie R; Huang, Shao-Ling; Kim, Hyunggun; Yin, Xing; Peng, Tao; Laing, Susan T; Klegerman, Melvin E; Rahbar, Mohammad H; Vela, Deborah; Genstler, Curtis; Haworth, Kevin J; Holland, Christy K; McPherson, David D.
Afiliación
  • Kee PH; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Moody MR; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Huang SL; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Kim H; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Yin X; Department of Bio-Mechatronic Engineering, Sungkyunkwan University, Suwon, Republic of Korea.
  • Peng T; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Laing ST; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Klegerman ME; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Rahbar MH; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Vela D; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Genstler C; Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, Texas.
  • Haworth KJ; Department of Pathology, Texas Heart Institute, Houston, Texas.
  • Holland CK; EKOS Corporation, Bothell, Washington.
  • McPherson DD; Department of Biomedical Engineering, University of Cincinnati, Cincinnati, Ohio.
JACC Basic Transl Sci ; 5(1): 1-11, 2020 Jan.
Article en En | MEDLINE | ID: mdl-32043017
ABSTRACT
Late in-stent restenosis remains a significant problem. Bare-metal stents were implanted into peripheral arteries in miniature swine, followed by direct intra-arterial infusion of nitric oxide-loaded echogenic liposomes (ELIPs) and anti-intercellular adhesion molecule-1 conjugated ELIPs loaded with pioglitazone exposed to an endovascular catheter with an ultrasonic core. Ultrasound-facilitated delivery of ELIP formulations into stented peripheral arteries attenuated neointimal growth. Local atheroma-targeted, ultrasound-triggered delivery of nitric oxide and pioglitazone, an anti-inflammatory peroxisome proliferator-activated receptor-γ agonist, into stented arteries has the potential to stabilize stent-induced neointimal growth and obviate the need for long-term antiplatelet therapy.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JACC Basic Transl Sci Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JACC Basic Transl Sci Año: 2020 Tipo del documento: Article